Kernal Biologics has technology that enables the delivery of messenger RNA therapies to a wider range of destinations in the body. The Series A financing comes as the startup works to advance its lead immuno-oncology program toward its first clinical test.
/PRNewswire/ Kernal Biologics, Inc. (Kernal Bio) a development-stage mRNA-technology company developing cancer therapeutics designed to improve patients .